{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"230"},{"groupId":"OG001","value":"301"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"344"},{"groupId":"OG001","value":"332"}],"units":"Participants"}],"title":"Hematology"},{"categories":[{"measurements":[{"groupId":"OG000","value":"278"},{"groupId":"OG001","value":"253"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"343"},{"groupId":"OG001","value":"328"}],"units":"Participants"}],"title":"Electrolytes"},{"categories":[{"measurements":[{"groupId":"OG000","value":"255"},{"groupId":"OG001","value":"195"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"343"},{"groupId":"OG001","value":"328"}],"units":"Participants"}],"title":"Liver Function"},{"categories":[{"measurements":[{"groupId":"OG000","value":"296"},{"groupId":"OG001","value":"258"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"343"},{"groupId":"OG001","value":"328"}],"units":"Participants"}],"title":"Chemistry"},{"categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"21"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"190"},{"groupId":"OG001","value":"155"}],"units":"Participants"}],"title":"Coagulation"}],"denoms":[{"counts":[{"groupId":"OG000","value":"356"},{"groupId":"OG001","value":"343"}],"units":"Participants"}],"description":"Reported here is the number of participants with at least one laboratory abnormality of any grade in measurements for hematology, electrolytes, liver function, chemistry, and coagulation.","groups":[{"description":"Participants received cemiplimab monotherapy","id":"OG000","title":"Cemiplimab"},{"description":"Participants received platinum-based doublet chemotherapy","id":"OG001","title":"Chemotherapy"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"SAF included all randomized participants who received any study drug. \"Overall number of participants analyzed\" includes all participants evaluable for this outcome measure, and \"number analyzed\" is the number of participants with at least one post-baseline value for that parameter.","reportingStatus":"POSTED","timeFrame":"Up to approximately 28 months","title":"Number of Participants With Laboratory Abnormalities","type":"SECONDARY","unitOfMeasure":"Participants"}